Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients-Reference-Cited by-同舟云学术

Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients

Published:2012-06-03 Issue:9 Volume:87 Page:865-869
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Ansell Stephen M.,Maurer Matthew J.,Ziesmer Steven C.,Slager Susan L.,Habermann Thomas M.,Link Brian K.,Witzig Thomas E.,Macon William R.,Dogan Ahmet,Cerhan James R.,Novak Anne J.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23259/fullpdf

Reference30 articles.

1. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: A study by the Groupe d'Etudes des Lymphomes de l'Adulte;Coiffier;Blood,2010

2. Ongoing improvement in outcomes for patients diagnosed as having Non-Hodgkin lymphoma from the 1990s to the early 21st century;Pulte;Arch Intern Med,2008

3. Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era;Gisselbrecht;J Clin Oncol,2010

4. Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantation;Costa;Bone Marrow Transplant,2008

5. The International Non-Hodgkin's Lymphoma Prognostic Factors Project;A predictive model for aggressive non-Hodgkin's lymphoma;N Engl J Med,1993

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives;Frontiers in Immunology;2024-03-15

2. Causal relationships between circulating inflammatory cytokines and diffuse large B cell lymphoma: a bidirectional Mendelian randomization study;Clinical and Experimental Medicine;2023-11-01

3. Prognostic and Diagnostic Significance of Chemokines and Cytokines in Cancer;Cytokine and Chemokine Networks in Cancer;2023

4. Body mass index and survival of patients with lymphoma;Leukemia & Lymphoma;2021-06-14

5. Identification of hub genes associated with the pathogenesis of diffuse large B-cell lymphoma subtype one characterized by host response via integrated bioinformatic analyses;PeerJ;2020-11-20